Industry: Pharmaceuticals, Biotechnology
AVT was founded by three scientific directors, formerly with Novartis, to commercialize their pivotal research in localized, ocular-based gene therapy. AVT is the only gene-based medicine company that is devoted to ocular applications. The founders bring with them the bulk of the technology that they developed at Novartis in a comprehensive and favorable licensing package. Importantly, AVT believes it has overcome the barriers that have encumbered previous gene therapy trials. A critical success factor is in targeting diseases of the eye where there are clear clinical pathways, predictable timelines, excellent pre-clinical models, and a high likelihood of therapeutic ( www.avtxinc.com )
Advanced Vision Therapies , Inc.
9700 Great Seneca Highway
Rockville, Maryland 20850
USA
Tel: (240) 453-8478
Fax: (240) 453-6208